UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO — SEC Form 4 filings
SEC reporting owner CIK 1019231. 13 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-05-01 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 8 filings — 2,663,609 shares, $50,000,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 52 legs across 5 filings — 95,059 shares, $367,382 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 347,237 shares @ $27.96 ($9,708,738) in Silver Point Specialty Lending Fund, filed 2026-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Silver Point Specialty Lending Fund (N) | 10% owner | 8 | 8 legs · 2,663,609 sh · $50,000,000 | — | — |
| Aileron Therapeutics, Inc. (ALRN) | 10% owner | 5 | — | 52 legs · 95,059 sh · $367,382 | — |
Form 4 filings — UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 47,481.36 @ $27.36 | EDGAR |
| 2026-04-30 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 86,674.64 @ $27.47 | EDGAR |
| 2026-04-01 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 170,984.01 @ $27.85 | EDGAR |
| 2026-03-02 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 245,231.47 @ $27.93 | EDGAR |
| 2026-02-02 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 347,236.69 @ $27.96 | EDGAR |
| 2025-12-29 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 609,115.65 @ $14.12 | EDGAR |
| 2025-11-26 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 622,251.72 @ $14.18 | EDGAR |
| 2025-10-27 | 4 | Silver Point Specialty Lending Fund (N) | Purchase (P): 534,633.56 @ $14.17 | EDGAR |
| 2024-06-17 | 4 | Aileron Therapeutics, Inc. (ALRN) | Sale (S): 1,900 @ $3.30 · Sale (S): 4,707 @ $3.25 | EDGAR |
| 2024-06-12 | 4 | Aileron Therapeutics, Inc. (ALRN) | Sale (S): 9,577 @ $3.30 · Sale (S): 5,250 @ $3.25 · Sale (S): 502 @ $3.35 · Sale (S): 9,341 @ $3.25 · Sale (S): 1 @ $3.27 | EDGAR |
| 2024-06-07 | 4 | Aileron Therapeutics, Inc. (ALRN) | Sale (S): 6,291 @ $3.30 · Sale (S): 1,100 @ $3.27 · Sale (S): 3,184 @ $3.30 · Sale (S): 1,564 @ $3.25 · Sale (S): 176 @ $3.30 | EDGAR |
| 2024-05-14 | 4/A | Aileron Therapeutics, Inc. (ALRN) | Sale (S): 3,100 @ $4.10 · Sale (S): 100 @ $4.11 · Sale (S): 1,750 @ $4.12 · Sale (S): 380 @ $4.13 · Sale (S): 1,600 @ $4.14 · Sale (S): 670 @ $4.15 · +10 more | EDGAR |
| 2024-05-01 | 4 | Aileron Therapeutics, Inc. (ALRN) | Sale (S): 6,680 @ $4.92 · Sale (S): 274 @ $4.93 · Sale (S): 100 @ $4.94 · Sale (S): 3,231 @ $5 · Sale (S): 13 @ $5.00 · Sale (S): 448 @ $5.03 · +18 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1019231 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →